| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |